Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development

被引:6
|
作者
Morrow N.C. [1 ]
机构
[1] Commonwealth Pharmacists Association, 1 Lambeth High Street, London
关键词
Cost effectiveness; Medication safety; Medicines management; Patient involvement; Patient utilisation; Pharmaceutical policy; Pharmacists; Prescribing; Strategic planning;
D O I
10.1186/s40545-015-0027-5
中图分类号
学科分类号
摘要
Across the world medicines are the ubiquitous technology in the diagnosis, treatment and prevention of disease. Pharmaceutical policy, as part of national health care policy, is concerned with the provision and use of medicines. Pharmacists are critical to the medicines management process, yet are often largely detached from policy development. Logically, they should inform Government policies which impact on their work or where their skills could be best applied to implement health care policy and medicines utilisation in particular. It therefore makes it critically important that the pharmaceutical profession engages with national policy makers and in the strategic planning for health care. This is the first of two articles directed to this specific issue. Firstly, it identifies a number of the practice challenges for pharmacy and medicines management, their implications for policy and the need for a balanced approach. Drawing from a range of international experiences some key learning points in respect of formulating and implementing national medicines policies are presented. Finally, reference is made to several authoritative evidence bases to inform the development of pharmaceutical practice and medicines management policies. © 2015 Morrow; licensee BioMed Central.
引用
收藏
页码:1 / 6
页数:5
相关论文
共 50 条
  • [1] Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: A framework for influence
    Morrow N.C.
    Journal of Pharmaceutical Policy and Practice, 8 (1) : 1 - 6
  • [2] Studying and evaluating pharmaceutical policy—becoming a part of the policy and consultative process
    Anna Birna Almarsdóttir
    Janine M. Traulsen
    Pharmacy World and Science, 2006, 28 : 6 - 12
  • [3] Studying and evaluating pharmaceutical policy -: becoming a part of the policy and consultative process
    Almarsdóttir, Anna Birna
    Traulsen, Janine M.
    PHARMACY WORLD & SCIENCE, 2006, 28 (01): : 6 - 12
  • [4] Cost-containment as part of pharmaceutical policy
    Almarsdóttir, AB
    Traulsen, JM
    PHARMACY WORLD & SCIENCE, 2005, 27 (03): : 144 - 148
  • [5] Cost-Containment as Part of Pharmaceutical Policy
    Anna Birna Almarsdóttir
    Janine M. Traulsen
    Pharmacy World and Science, 2005, 27 : 144 - 148
  • [6] Challenges and opportunities for the development of a national pharmaceutical policy in Mexico
    Wirtz, Veronika J.
    Dreser, Anahi
    Heredia-Pi, Ileana
    SALUD PUBLICA DE MEXICO, 2013, 55 (03): : 329 - 336
  • [7] The argument for pharmaceutical policy
    Janine Morgall Traulsen
    Anna Birna Almarsdóttir
    Pharmacy World and Science, 2005, 27 : 7 - 12
  • [8] The argument for pharmaceutical policy
    Traulsen, JM
    Almarsdóttir, AB
    PHARMACY WORLD & SCIENCE, 2005, 27 (01): : 7 - 12
  • [9] Editorial: Pharmaceutical policy, impact and health outcomes
    Kwon, Hye-Young
    Godman, Brian
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] Pharmaceutical policy and the pharmacy profession
    Traulsen, AM
    Almarsdöttir, AB
    PHARMACY WORLD & SCIENCE, 2005, 27 (05): : 359 - 363